# Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)

> **NCT00671073** · PHASE2 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 427 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Oglemilast
- **DRUG:** Placebo
- **DRUG:** Oglemilast
- **DRUG:** Oglemilast

## Key facts

- **NCT ID:** NCT00671073
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05-05
- **Primary completion:** 2009-05-15
- **Final completion:** 2009-05-15
- **Target enrollment:** 427 (ACTUAL)
- **Last updated:** 2019-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00671073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00671073, "Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-09-23 from https://api.ai-analytics.org/clinical/NCT00671073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*